VALERIE HALL-GLASS: Open Payments
NPI 1447586508 · WAYNESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$620 in 40 payments from 8 companies in 2025. Trend: 2023 $642 · 2024 $520 · 2025 $620
Food & beverage: $620
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $237 |
| Novo Nordisk Inc | 4 | $89 |
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| Exact Sciences Corporation | 3 | $67 |
| PFIZER INC. | 3 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Medtronic, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: VRAYLAR, Wegovy, Cologuard Collection Kit, NURTEC ODT, UBRELVY, AIRSUPRA, QULIPTA, XIFAXAN.
Industry payments across TN — which companies pay providers there.
